Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma
Condition(s):Glioblastoma Multiforme of BrainLast Updated:January 2, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Glioblastoma Multiforme of BrainLast Updated:January 2, 2024Not yet recruiting
Condition(s):GlioblastomaLast Updated:December 22, 2023Not yet recruiting
Condition(s):GlioblastomaLast Updated:September 27, 2022Not yet recruiting
Condition(s):Glioblastoma; Glioblastoma Multiforme; GliosarcomaLast Updated:March 8, 2024Not yet recruiting
Condition(s):GlioblastomasLast Updated:October 14, 2020Unknown status
Condition(s):GlioblastomaLast Updated:March 25, 2024Active, not recruiting
Condition(s):GlioblastomaLast Updated:June 12, 2023Not yet recruiting
Condition(s):Glioblastoma MultiformeLast Updated:July 24, 2023Not yet recruiting
Condition(s):GlioblastomaLast Updated:November 2, 2023Not yet recruiting
Condition(s):GlioblastomaLast Updated:January 25, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.